NEW YORK, March 28, 2019 /PRNewswire/ — EmblemHealth, one of the nation’s largest non-profit health insurers, and its partner, AdvantageCare Physicians (ACPNY), one of New York’s largest primary and specialty care practices, announced today they are joining forces with HealthReveal, a clinical AI company dedicated to curating and deploying the latest in scientific medical evidence to improve patient outcomes and quality of life. ACPNY has integrated HealthReveal’s clinical tool into its care model to improve patients’ health by harvesting the latest research-backed clinical recommendations that are actionable and personalized. HealthReveal’s technology was piloted in partnership with physician leaders at three ACPNY medical offices beginning in 2018 and will be deployed across all of ACPNY’s sites by May 2019.
ACPNY’s physicians made the decision to launch HealthReveal in all sites to ensure that their practice will be able to deploy the latest scientific research and best practices as they become available to improve care for patients with chronic disease before potentially catastrophic complications occur. This emphasis on proactive care is aligned with ACPNY’s team-based, coordinated approach to population health.
“ACPNY is an incubator for innovation,” said Karen Ignagni, President and CEO of EmblemHealth. “This initiative represents the next generation of population health, harvesting for care teams the latest science and best practices in real time.”
Today, HealthReveal’s technology is integrated into ACPNY’s Epic electronic medical record system. When HealthReveal detects an opportunity for an optimal course of treatment, it proactively issues a “Reveal” to clinicians with a personalized and precise recommendation. This enables clinicians and care teams to have the benefit of this information in real time and within their existing workflow, without the need for separate or additional applications.
For example, a Reveal was issued for a patient with atrial fibrillation and an elevated risk of stroke to consider pharmacological stroke prevention. The physician carefully reviewed the Reveal and took action by prescribing oral anticoagulation to the patient. Stroke risk can be reduced by 66 percent in properly anticoagulated patients.
“Our clinical approach starts with patient centered primary care,” says Dr. Navarra Rodriguez, President and Chief Medical Officer of ACPNY. “Our partnership with HealthReveal reflects our commitment to putting evidence-based care into practice.”
“HealthReveal’s goal is to help drive continuous, guideline-directed clinical care for all patients, and through this partnership with AdvantageCare Physicians and EmblemHealth, we are bringing personalized, clinically-effective care to thousands more New Yorkers,” said Dr. Lonny Reisman, founder and CEO of HealthReveal. “Our solution allows clinicians to offer personalized patient care backed by the latest medical research and insights, and allows health plans to support optimal care for members with chronic disease who are at risk for costly and catastrophic outcomes.”
About AdvantageCare Physicians
EmblemHealth partners with AdvantageCare Physicians, the largest primary and specialty care practice in the New Yorkarea, to provide quality, personalized care that is focused on the whole patient. With medical offices across the five boroughs and Long Island, AdvantageCare Physicians takes a team-based approach to care where physicians work with nurses, social workers, nutritionists, behavioral health specialists and other professionals. www.ACPNY.com.
EmblemHealth is one of the nation’s largest nonprofit health insurers, with 3.1 million members and an 80-year legacy of serving New York’s communities. The company offers a full range of commercial and government-sponsored health plans to employers, individuals and families, as well as convenient community resources. As a market leader in value-based care, EmblemHealth partners with top doctors and hospitals to deliver quality, affordable care. For more information, visit emblemhealth.com.
HealthReveal is a healthcare technology company that uses artificial intelligence to analyze a patient’s medical data, supporting clinicians in applying the latest clinical evidence and medical guidelines to the treatment of chronic disease. When discrepancies emerge, HealthReveal suggests treatment options (“Reveals”) to help clinicians and care teams practice evidence-based medicine, eliminate variations in care, reduce long-term medical costs, and save lives. Learn more at www.healthreveal.com.
* to be directed to the original article: